TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year (Emma Court/Bloomberg)
Emma Court / Bloomberg:TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year — - TrialSpark expands from clinical trials into developing drugs — Company raised $156 million, is valued at more than $1 billion
Landwebs
0
4
Emma Court / Bloomberg:
TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year — - TrialSpark expands from clinical trials into developing drugs — Company raised $156 million, is valued at more than $1 billion
/cdn.vox-cdn.com/uploads/chorus_asset/file/24430706/elon_musk_twitter_for_you.png)
